Alcon AG
ALC85.350USD
-0.050-0.06%
Close 06/23, 16:00（ET）Quotes delayed by 15 min
42.21BMarket Cap
41.47P/E TTM
More Details of Alcon AG Company
Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.
Company Info
Ticker SymbolALC
Company nameAlcon AG
IPO dateApr 09, 2019
Founded at2018
CEOMr. David J. Endicott
Number of employees25599
Security typeOrdinary Share
Fiscal year-endApr 09
AddressRue Louis d'Affry 6
CityFRIBOURG
Stock exchangeSIX Swiss Exchange
CountrySwitzerland
Postal code1700
Phone41589113800
Websitehttps://www.alcon.ch/
Ticker SymbolALC
IPO dateApr 09, 2019
Founded at2018
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer
Chief Financial Officer
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer
Chief Operating Officer
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%
Mr. Scott Harlan Maw
Mr. Scott Harlan Maw
Independent Director
Independent Director
17.26K
+14.57%
Ms. Ines Poeschel
Ms. Ines Poeschel
Independent Director
Independent Director
12.08K
+15.09%
Ms. Lynn Dorsey Bleil
Ms. Lynn Dorsey Bleil
Independent Director
Independent Director
10.94K
+13.26%
Mr. Leon Sergio Duplan Fraustro
Mr. Leon Sergio Duplan Fraustro
Senior Vice President, President - Americas
Senior Vice President, President - Americas
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer
Chief Financial Officer
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer
Chief Operating Officer
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%
Revenue Breakdown
Currency: USDUpdated: Sun, Apr 6
Currency: USDUpdated: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
By BusinessUSD
Name
Revenue
Proportion
Consumables
2.86B
29.09%
Contact lenses
2.61B
26.53%
Implantables
1.77B
18.05%
Ocular health
1.71B
17.33%
Equipment/other
886.00M
9.01%
By RegionUSD
Name
Revenue
Proportion
United States
4.51B
45.86%
Other
4.13B
42.01%
China
560.00M
5.69%
Japan
554.00M
5.63%
Switzerland
79.00M
0.80%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Consumables
2.86B
29.09%
Contact lenses
2.61B
26.53%
Implantables
1.77B
18.05%
Ocular health
1.71B
17.33%
Equipment/other
886.00M
9.01%
Shareholding Stats
Updated: Tue, May 20
Updated: Tue, May 20
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
3.98%
Fidelity Management & Research Company LLC
3.01%
Norges Bank Investment Management (NBIM)
2.53%
Aristotle Capital Management, LLC
2.45%
Other
83.10%
Shareholders
Shareholders
Proportion
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
3.98%
Fidelity Management & Research Company LLC
3.01%
Norges Bank Investment Management (NBIM)
2.53%
Aristotle Capital Management, LLC
2.45%
Other
83.10%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
28.88%
Investment Advisor
27.17%
Bank and Trust
4.28%
Sovereign Wealth Fund
2.61%
Hedge Fund
2.37%
Research Firm
1.61%
Pension Fund
1.40%
Individual Investor
0.13%
Insurance Company
0.10%
Other
31.45%
Institutional Shareholding
Updated: Sun, Jan 19
Updated: Sun, Jan 19
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
1620
379.56M
75.96%
+37.51M
2024Q4
1636
370.45M
74.13%
+31.24M
2024Q3
1624
333.39M
66.72%
-2.12M
2024Q2
1594
337.16M
67.47%
-33.61M
2024Q1
1583
337.34M
67.51%
+4.25M
2023Q4
1598
326.79M
65.39%
-10.87M
2023Q3
1582
325.37M
65.11%
-21.48M
2023Q2
1575
329.22M
65.88%
-15.79M
2023Q1
1566
324.92M
65.02%
+2.70M
2022Q4
1564
305.91M
61.22%
-40.51M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Advisors (UK) Limited
24.68M
4.94%
--
--
Dec 31, 2024
The Vanguard Group, Inc.
19.35M
3.87%
+211.11K
+1.10%
Dec 31, 2024
Fidelity Management & Research Company LLC
12.09M
2.42%
+611.30K
+5.32%
Dec 31, 2024
Norges Bank Investment Management (NBIM)
12.62M
2.53%
+276.47K
+2.24%
Dec 31, 2024
Aristotle Capital Management, LLC
12.83M
2.57%
-82.71K
-0.64%
Dec 31, 2024
UBS Fund Management (Switzerland) AG
11.93M
2.39%
+211.04K
+1.80%
Dec 31, 2024
Zürcher Kantonalbank (Asset Management)
8.93M
1.79%
+306.70K
+3.56%
Dec 31, 2024
Harding Loevner LP
8.48M
1.7%
-795.85K
-8.58%
Dec 31, 2024
AKO Capital LLP
5.88M
1.18%
-281.54K
-4.57%
Dec 31, 2024
T. Rowe Price Investment Management, Inc.
15.08M
3.02%
+8.71M
+136.76%
Feb 03, 2025
View more
Related ETFs
Updated: Fri, Jun 6
Updated: Fri, Jun 6
Name
Proportion
iShares MSCI Switzerland ETF
2.8%
Franklin FTSE Switzerland ETF
2.79%
Global X Aging Population ETF
2.72%
First Trust Switzerland Alphadex Fund
2.33%
Running Oak Efficient Growth ETF
1.89%
First Trust Indxx Medical Devices ETF
1.84%
Global X S&P Catholic Values Developed ex-US ETF
1.33%
BNY Mellon Women's Opportunities ETF
1.28%
Nuveen Growth Opportunities ETF
0.78%
iShares Health Innovation Active ETF
0.66%
View more
iShares MSCI Switzerland ETF
Proportion2.8%
Franklin FTSE Switzerland ETF
Proportion2.79%
Global X Aging Population ETF
Proportion2.72%
First Trust Switzerland Alphadex Fund
Proportion2.33%
Running Oak Efficient Growth ETF
Proportion1.89%
First Trust Indxx Medical Devices ETF
Proportion1.84%
Global X S&P Catholic Values Developed ex-US ETF
Proportion1.33%
BNY Mellon Women's Opportunities ETF
Proportion1.28%
Nuveen Growth Opportunities ETF
Proportion0.78%
iShares Health Innovation Active ETF
Proportion0.66%
Dividend
A total of
400.00M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Mar 01, 2022
ALC.NB Final Cash Dividend of gross CHF 0.2 paid on May 05, 2022 going ex on Apr 29, 2022
May 04, 2022
May 05, 2022
May 03, 2022
Feb 24, 2021
ALC.NB Final Cash Dividend of gross CHF 0.1 paid on May 06, 2021 going ex on May 04, 2021
May 05, 2021
May 06, 2021
May 04, 2021
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
